HCP, Inc. (NYSE:HCP) was upgraded by investment analysts at Goldman Sachs Group, Inc. (The) from a “neutral” rating to a “buy” rating in a research report issued on Wednesday.
Several other research firms have also weighed in on HCP. Vetr lowered HCP from a “buy” rating to a “hold” rating and set a $30.75 price target on the stock. in a research report on Tuesday, December 20th. Barclays PLC reissued an “equal weight” rating and set a $32.00 price target on shares of HCP in a research report on Thursday, January 5th. RBC Capital Markets set a $30.00 target price on HCP and gave the company a “hold” rating in a research note on Tuesday, January 3rd. Zacks Investment Research upgraded HCP from a “hold” rating to a “buy” rating and set a $41.00 target price on the stock in a research note on Wednesday, October 5th. Finally, Bank of America Corporation upgraded HCP from an “underperform” rating to a “neutral” rating and set a $38.50 target price on the stock in a research note on Tuesday, October 4th. Three investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and three have issued a buy rating to the company’s stock. HCP has an average rating of “Hold” and an average target price of $33.35.
Source: American Banking and Market News